<DOC>
	<DOC>NCT01990677</DOC>
	<brief_summary>To test the effect oral eplerenone versus placebo in patients with central serious chorioretinopathy .</brief_summary>
	<brief_title>Eplerenone for the Treatment of Central Serous Chorioretinopathy</brief_title>
	<detailed_description>To evaluate the effect of oral eplerenone compared to placebo in patients with central serous chorioretinopathy (CSCR) on sub-foveal (small part of retina) fluid using optical coherence tomography (OCT).</detailed_description>
	<mesh_term>Central Serous Chorioretinopathy</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>Age 18 and over Ability to give written informed consent Subretinal fluid under fovea seen on OCT Diagnosis of CSCR: classification is at the discretion of the investigator, but general guidelines are 1. Acute first episode or symptoms less than one month prior to presentation 2. Chronic previously documented subfoveal fluid, any prior treatment, symptoms for over 3 months, or &lt;50% reduction in fluid thickness on OCT after 3 months. Age under 18 Impaired decisionmaking ability At initial laboratory screening serum potassium &gt;5.5 mEq/L (milliequivalent) At initial laboratory screening serum creatinine &gt;2 mg/dL in men and &gt;1.8 mg/dL in women or decreased renal function by creatinine clearance less than 50 mL/min Absence of subfoveal fluid Any patient with prior treatment for CSCR within 3 months of enrollment Patients taking potassium supplements or potassiumsparing diuretics spironolactone, amiloride, and triamterene and/or potent CYP3A4 (cytochrome) inhibitors (amifostine, cyclosporine, fluconazole, itraconazole, ketoconazole, mifepristone, posaconazole, potassium salts, rituximab, tacrolimus, voriconazole nefazodone, troleandomycin, clarithromycin, ritonavir, and nelfinavir) Women who are pregnant or are actively trying to conceive Patients with type 1 or type 2 diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Central Serous Chorioretinopathy</keyword>
	<keyword>csr</keyword>
	<keyword>cscr</keyword>
	<keyword>eplerenone</keyword>
	<keyword>vision</keyword>
	<keyword>choroid</keyword>
	<keyword>retina</keyword>
	<keyword>acute</keyword>
	<keyword>chronic</keyword>
</DOC>